1. Home
  2. SGHT vs OZ Comparison

SGHT vs OZ Comparison

Compare SGHT & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • OZ
  • Stock Information
  • Founded
  • SGHT 2011
  • OZ 2020
  • Country
  • SGHT United States
  • OZ United States
  • Employees
  • SGHT N/A
  • OZ N/A
  • Industry
  • SGHT Medical Specialities
  • OZ
  • Sector
  • SGHT Health Care
  • OZ
  • Exchange
  • SGHT Nasdaq
  • OZ Nasdaq
  • Market Cap
  • SGHT 304.4M
  • OZ 255.0M
  • IPO Year
  • SGHT 2021
  • OZ N/A
  • Fundamental
  • Price
  • SGHT $3.76
  • OZ $69.00
  • Analyst Decision
  • SGHT Buy
  • OZ
  • Analyst Count
  • SGHT 6
  • OZ 0
  • Target Price
  • SGHT $6.80
  • OZ N/A
  • AVG Volume (30 Days)
  • SGHT 264.4K
  • OZ 4.0K
  • Earning Date
  • SGHT 11-07-2024
  • OZ 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • OZ N/A
  • EPS Growth
  • SGHT N/A
  • OZ N/A
  • EPS
  • SGHT N/A
  • OZ N/A
  • Revenue
  • SGHT $79,543,000.00
  • OZ $2,092,000.00
  • Revenue This Year
  • SGHT $3.06
  • OZ N/A
  • Revenue Next Year
  • SGHT $10.33
  • OZ N/A
  • P/E Ratio
  • SGHT N/A
  • OZ N/A
  • Revenue Growth
  • SGHT N/A
  • OZ N/A
  • 52 Week Low
  • SGHT $2.58
  • OZ $42.75
  • 52 Week High
  • SGHT $8.45
  • OZ $79.26
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 31.07
  • OZ 55.56
  • Support Level
  • SGHT $3.65
  • OZ $69.00
  • Resistance Level
  • SGHT $3.85
  • OZ $69.78
  • Average True Range (ATR)
  • SGHT 0.29
  • OZ 0.94
  • MACD
  • SGHT -0.04
  • OZ 0.11
  • Stochastic Oscillator
  • SGHT 7.14
  • OZ 66.68

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.

Share on Social Networks: